General description

Kills growing cells by interfering with the terminal reaction in bacterial wall synthesis. Active against Gram-negative bacteria. Inactivated by lactamases. Suitable for use in research that uses ampicillin-resistant plasmids.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Nakajima, M., et al. 1994. Neurosci. Lett.176, 161.Wu, M.H., and Yung, B.Y. 1994. Eur. J. Pharmacol.270, 203.Betzel, C., et al. 1993. Biochim. Biophys. Acta1161, 47.Yung, B.Y., et al. 1992. Int. J. Cancer52, 317.Martin, S.J., et al. 1990. J. Immunol.145, 1859.Yung, B.Y., et al. 1990. Cancer Res.50, 5987.White, R.J., and Phillips, D.R. 1985. Biochemistry27, 9122.Madharavao, M., et al. 1978. J. Med. Chem. 21, 958.Sengupta, S.K., et al. 1975. J. Med. Chem. 18, 1175.

Packaging

5, 25 g in Plastic ampoule

Reconstitution

Following reconstitution, aliquot and freeze (-20°C). Aqueous stock solutions are stable for up to 1 month at -20°C. Product is heat-resistant and stable between pH 2 and 11.

Warning

Toxicity: Irritant (B)